Allergenic Products Advisory Committee
Committee Meeting on October 25, 2011, from 8:30 a.m. to approximately 1:30 p.m.
Agenda: On October 25, 2011, the committee will meet in open session to hear and discuss CBER’s review of scientific and medical literature concerning the use of non-standardized allergen extracts in the diagnosis and treatment of allergic disease. FDA is announcing the availability of this report entitled ‘‘CBER’s Report of Scientific and Medical Literature and Information on Non-Standardized Allergen Extracts in the Diagnosis and Treatment of Allergic Disease’’ elsewhere in this issue of the Federal Register.
Monday, October 3, 2011
Subscribe to:
Post Comments (Atom)


No comments:
Post a Comment